Court of Appeals for the Seventh Circuit June 13, 2005, 04-1171 (Cerabio, LLC v. Wright Medical Tech)

Also known as

United States · · · 13-06-2005

In the

United States Court of Appeals

For the Seventh Circuit

____________

No. 04-1171

CERABIO LLC and PHILLIPS

PLASTICS CORPORATION,

Plaintiffs-Appellees,

v.

WRIGHT MEDICAL

TECHNOLOGY, INC.,

Defendant-Appellant.

____________

Appeal from the United States District Court

for the Western District of Wisconsin.

No. 03 C 92—John C. Shabaz, Judge.

____________

ARGUED SEPTEMBER 14, 2004—DECIDED JUNE 13, 2005

____________

Before CUDAHY, ROVNER, and WILLIAMS, Circuit Judges.

ROVNER, Circuit Judge. In this contract dispute,

CERAbio, LLC and its sole member, Phillips Plastics

Corporation (collectively “CERAbio”), claims that it deliv-

ered all of the assets of the corporation, including its

technological know-how, to Wright Medical Technology, Inc.

(Wright), but that Wright failed to pay the remaining half

of the agreed-upon sales price. Wright countered that not

only was the technological knowledge provided by CERAbio

2 No. 04-1171

worthless and that it therefore had not performed its end of

the deal, but that CERAbio had also committed fraud and

had been negligent both in the formation and performance

of the contract. Upon CERAbio’s motion, the district court

granted summary judgment on Wright’s tort counter claims.

At trial, the jury ruled in favor of CERAbio on the contract

claims. On appeal, Wright challenges the district court’s

ruling on summary judgment as well as an evidentiary rul-

ing at trial. We affirm the summary judgment ruling, but

reverse and remand to the district court to correct the effect

of the erroneous evidentiary ruling, which we agree was in

error.

I.

Wright designs, manufactures, and sells medical devices

and products, including bone replacement products known

as biologics, frequently used during implantation surgery to

replace lost bone and provide a framework for new bone

growth. In the late 1990’s, CERAbio developed a bone re-

placement product made from tricalcium phosphate (“TCP”).

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.